-Reuters India's move to strip German drugmaker Bayer of its exclusive rights to a cancer drug has set a precedent that could extend to other treatments, including modern HIV/AIDS drugs, in a major blow to global pharmaceutical firms, experts say.  On Monday, the Indian Patent Office effectively ended Bayer's monopoly for its Nexavar drug and issued its first-ever compulsory license allowing local generic maker Natco Pharma to make and sell the drug...

Patients battling cancer, infections and mental illness joined a rally here today beseeching the government to reject a trade pact with the European Union that they fear will threaten the availability of inexpensive generic medicines in India. An estimated 2,000 people, many among them infected with HIV, walked along Delhi’s Parliament Street on a day when Indian and EU officials were negotiating a free trade agreement in Brussels. Health activists and lawyers...

Said it failed to state ethical aspects involved in the study Proposal was based on the assumption that vaccine was safe and efficacious: PHFI Brinda demands compensation for all subjects victimised by vaccine programme The proposal for conducting the now controversial “Post-licensure observational study of Human Papilloma Virus (HPV) vaccination: Demonstration Project,” carried out by a non-governmental organisation PATH for two major pharmaceutical companies, had been turned down by the Public Health Foundation...

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global After months of prevarication, the European Union has stated publicly that the free trade agreement (FTA) it signs with India will include provisions for data exclusivity because “it is extremely important for research and innovation’’. That’s what European Union ambassador Daniele Smadja told journalists in Delhi on January 21. Smadja’s...

The government may levy duty on two important drug ingredients imported from China and Mexico to protect local suppliers. The move could increase prices of popular antibiotics for consumers besides threatening business of about two dozen small drugmakers. The commerce ministry has recommended anti-dumping duty on Penicillin G Potassium and 6 APA, after Indian suppliers complained Chinese and Mexican firms are shipping it at a low price to kill competition from...